OMER

OMEROS CORP

Latest Form 4:Sale$190KbyBorges David J. (VP, Finance & CAO) · filed Aug 25, 2026

OMEROS CORP (OMER) has 7 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Aug 25, 2026.

The most active filer is VP, Finance & CAO Borges David J. with 5 filings. Insiders have net sold $655K over the trailing 6 months.

  • Industry:Biotechnology
  • CEO:Gregory A. Demopulos
  • Employees:202
  • HQ:Seattle, WA, US
  • IPO:2009-10-08

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.4M

reported sales (SEC code S)

Unique Insiders

2

in the rolling window

Market Cap

$1.4B

latest known value

Source
Sale$190KAug 25SEC ↗
Sale$17KAug 25SEC ↗
Sale$277KAug 21SEC ↗
Borges David J.First in 7 months
Sale$85KAug 17SEC ↗
Cable Thomas J.First filing
Sale$87KMay 27SEC ↗
Borges David J.First filing
Sale$382KJan 14SEC ↗
Borges David J.First filing
Sale$369KJan 14SEC ↗

Related companies

OMEROS CORP is in the Healthcare sector.